# Estrella Immunopharma, Inc.: Form 8-K/A, filed Nov 7, 2024

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 8-K/A
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 17:27 ET
- Period: 2024-08-14
- Accession: 0001213900-24-095507
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024095507/ea022043401-8ka_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390024095507/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390024095507/ea022043401-8ka_estrella.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-095507. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.
